Review



rabbit anti human integrin β3  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc rabbit anti human integrin β3
    Rabbit Anti Human Integrin β3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 208 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human integrin β3/product/Cell Signaling Technology Inc
    Average 96 stars, based on 208 article reviews
    rabbit anti human integrin β3 - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    96
    Cell Signaling Technology Inc rabbit anti human integrin β3
    Rabbit Anti Human Integrin β3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human integrin β3/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti human integrin β3 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti human integrin β3 antibody
    Rabbit Anti Human Integrin β3 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human integrin β3 antibody/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti human integrin β3 antibody - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit anti-human integrin β3
    Identification of <t>integrin</t> <t>β3</t> as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input
    Rabbit Anti Human Integrin β3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human integrin β3/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit anti-human integrin β3 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc rabbit anti human integrin β3 antibodies
    Identification of <t>integrin</t> <t>β3</t> as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input
    Rabbit Anti Human Integrin β3 Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human integrin β3 antibodies/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    rabbit anti human integrin β3 antibodies - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology polyclonal antibodies rabbit anti human αv, α2, α3, α5, β1, β3, β5 integrin
    Identification of <t>integrin</t> <t>β3</t> as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input
    Polyclonal Antibodies Rabbit Anti Human αv, α2, α3, α5, β1, β3, β5 Integrin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal antibodies rabbit anti human αv, α2, α3, α5, β1, β3, β5 integrin/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    polyclonal antibodies rabbit anti human αv, α2, α3, α5, β1, β3, β5 integrin - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-integrin β3 (rabbit anti-human
    Identification of <t>integrin</t> <t>β3</t> as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input
    Anti Integrin β3 (Rabbit Anti Human, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-integrin β3 (rabbit anti-human/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-integrin β3 (rabbit anti-human - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore rabbit anti-human integrin β3
    Identification of <t>integrin</t> <t>β3</t> as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input
    Rabbit Anti Human Integrin β3, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human integrin β3/product/Millipore
    Average 90 stars, based on 1 article reviews
    rabbit anti-human integrin β3 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Identification of integrin β3 as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: Identification of integrin β3 as a kallistatin-binding protein. a The pull-down assay with the recombinant human kallistatin. The membrane proteins of NCI-H446 cell were pulled down by recombinant human kallistatin and subjected to immunoblotting with antibody anti-integrinβ3 ( upper panel ) and anti-kallistatin, respectively ( lower panel ). The membrane proteins incubated with Ni–NTA alone were used as control. b Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-kallistatin antibody followed by immunoblotting against integrin β3 and kallistatin, respectively. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitatedas control. Co-immunoprecipitation sample without treated with Protein A-Sepharose were used to immunoblotting as input. c Immunoprecipitation of membrane proteins of NCI-H446 cell with anti-Integrin β3 antibody followed by immunoblotting against integrin β3 and kallistatin. The extracts of NCI-H446 cells treated without kallistatin were immunoprecipitated as control. Co-immunoprecipitation samples without treated with Protein A-Sepharose were used to immunoblotting as input

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Binding Assay, Pull Down Assay, Recombinant, Membrane, Western Blot, Incubation, Control, Immunoprecipitation

    The effect of kallistatin on viability of NCI-H446 and CHO cells. a The effects of kallistatin on the viability of NCI-H446 cells in a dose dependent manner. N = 6 × 3 for each group. * P < 0.05. b Detect integrin expression in NCI-H446 and CHO cells by western blot. c Effect of kallistatin on cell viability in CHO cells which is lack of integrin β3 genes as a negative control. N = 6 × 3 for each group

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: The effect of kallistatin on viability of NCI-H446 and CHO cells. a The effects of kallistatin on the viability of NCI-H446 cells in a dose dependent manner. N = 6 × 3 for each group. * P < 0.05. b Detect integrin expression in NCI-H446 and CHO cells by western blot. c Effect of kallistatin on cell viability in CHO cells which is lack of integrin β3 genes as a negative control. N = 6 × 3 for each group

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Expressing, Western Blot, Negative Control

    Integrin β3 is involved in the effects of kallistatin on viability of NCI-H446 cells. a Integrin β3 expression in NCI-H446 cells was downregulated by siRNA in a time-dependent manner that was analyzed by immunoblotting (N = 3). Housekeeping proteins GAPDH are useful as loading controls for immunoblotting and protein normalization. The data are expressed as mean ± SD from three independent experiments. *P < 0.05. b Inhibition effect of kallistatin on the viability of NCI-H446 cells was attenuated by treatment of siRNA. N = 6×3 for each group. N.C siRNA was used as negative control, respectively. *P < 0.05, # P < 0.05, # comparison of the differences between column 2 and 3 and between column 4 and 5. b Inhibition effect of kallistatin on the viability of NCI-H446 cells was attenuated by antibody against integrin β3. N = 6 × 3 for each group. Mouse IgG were used as negative control. *P < 0.05, # P < 0.05, # comparison of the differences between column 2 and 3 and between column 4 and 5

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: Integrin β3 is involved in the effects of kallistatin on viability of NCI-H446 cells. a Integrin β3 expression in NCI-H446 cells was downregulated by siRNA in a time-dependent manner that was analyzed by immunoblotting (N = 3). Housekeeping proteins GAPDH are useful as loading controls for immunoblotting and protein normalization. The data are expressed as mean ± SD from three independent experiments. *P < 0.05. b Inhibition effect of kallistatin on the viability of NCI-H446 cells was attenuated by treatment of siRNA. N = 6×3 for each group. N.C siRNA was used as negative control, respectively. *P < 0.05, # P < 0.05, # comparison of the differences between column 2 and 3 and between column 4 and 5. b Inhibition effect of kallistatin on the viability of NCI-H446 cells was attenuated by antibody against integrin β3. N = 6 × 3 for each group. Mouse IgG were used as negative control. *P < 0.05, # P < 0.05, # comparison of the differences between column 2 and 3 and between column 4 and 5

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Expressing, Western Blot, Inhibition, Negative Control, Comparison

    Integrin β3 is involved in the inhibition effect of kallistatin on proliferation of NCI-H446 cells. a Proliferation of NCI-H446 cells was inhibited in presence of kallistatin. Proliferating NCI-H446 cells were labeled with EdU ( red ). Cell nuclei were stained with Hoechst 33,342 ( blue ). b The percentage of EdU-positive NCI-H446 cells was quantified. Kallistatin inhibited the proliferation of NCI-H446 cells in a dose-dependent manner. Data were presented as mean ± SD (N = 6). * P < 0.05. c Down-regulation of integrin β3 by siRNA attenuated the proliferation inhibition of NCI-H446 cells at 48 h post kallistatin treatment as measured by EdU assay. d The percentage of EdU-positive NCI-H446 cells was quantified. Data were presented as mean ± SD (N = 6). N.C siRNA was used as negative control. *P < 0.05, # P < 0.05, # comparison of the differences between column 1 and 2 and between column 3 and 4. e Blockage of integrin β3 with antibody (anti-integrin β3) attenuated the viability inhibition of NCI-H446 cells at 48 h post kallistatin treatment as measured by EdU assay. f The percentage of EdU-positive NCI-H446 cells was quantified. Data were presented as mean ± SD (N = 6). Mouse IgG was used as negative control. *P < 0.05, # P < 0.05, # comparison of the differences between column 1 and 2 and between column 3 and 4

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: Integrin β3 is involved in the inhibition effect of kallistatin on proliferation of NCI-H446 cells. a Proliferation of NCI-H446 cells was inhibited in presence of kallistatin. Proliferating NCI-H446 cells were labeled with EdU ( red ). Cell nuclei were stained with Hoechst 33,342 ( blue ). b The percentage of EdU-positive NCI-H446 cells was quantified. Kallistatin inhibited the proliferation of NCI-H446 cells in a dose-dependent manner. Data were presented as mean ± SD (N = 6). * P < 0.05. c Down-regulation of integrin β3 by siRNA attenuated the proliferation inhibition of NCI-H446 cells at 48 h post kallistatin treatment as measured by EdU assay. d The percentage of EdU-positive NCI-H446 cells was quantified. Data were presented as mean ± SD (N = 6). N.C siRNA was used as negative control. *P < 0.05, # P < 0.05, # comparison of the differences between column 1 and 2 and between column 3 and 4. e Blockage of integrin β3 with antibody (anti-integrin β3) attenuated the viability inhibition of NCI-H446 cells at 48 h post kallistatin treatment as measured by EdU assay. f The percentage of EdU-positive NCI-H446 cells was quantified. Data were presented as mean ± SD (N = 6). Mouse IgG was used as negative control. *P < 0.05, # P < 0.05, # comparison of the differences between column 1 and 2 and between column 3 and 4

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Inhibition, Labeling, Staining, EdU Assay, Negative Control, Comparison

    Reduction effects of kallistatin on NCI-H446 cells migration can be diminished by inhibition of integrin β3. A Optical microscopy imaging of the cells in experimental transwells. The cells have migrated from upper chamber to underside of the membrane between the two chambers after treatment with kallistatin. a saline; b 12.5 μg/ml kallistatin; c 50 μg/ml kallistatin; d 200 μg/ml kallistatin. B Statistic analysis for the migrated cell numbers. C Either down-regulation of integrin β3 by siRNA or blockage of integrin β3 with antibody (anti-integrin β3) attenuated the reduction effects of kallistatin on NCI-H446 cell migration. a Transfected with negative control siRNA and treated with saline; b transfected with negative control siRNA and treated with 200 μg/ml kallistatin; c transfected with integrin β3 siRNA and treated with saline; d transfected with integrin β3 siRNA and treated with 200 μg/ml kallistatin; e treated with mouse IgG and saline; f treated with mouse IgG and 200 μg/ml kallistatin; g treated with integrin β3 antibody and saline; h treated with integrin β3 antibody and 200 μg/ml kallistatin. D Statistic analysis for the migrated cell numbers. Data were presented as mean ± SD (N = 6). *P < 0.05. # P < 0.05, # comparison of the differences between column 1 and 2 and between column 3 and 4, and the differences between column 5 and 6 and between 7 and 8

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: Reduction effects of kallistatin on NCI-H446 cells migration can be diminished by inhibition of integrin β3. A Optical microscopy imaging of the cells in experimental transwells. The cells have migrated from upper chamber to underside of the membrane between the two chambers after treatment with kallistatin. a saline; b 12.5 μg/ml kallistatin; c 50 μg/ml kallistatin; d 200 μg/ml kallistatin. B Statistic analysis for the migrated cell numbers. C Either down-regulation of integrin β3 by siRNA or blockage of integrin β3 with antibody (anti-integrin β3) attenuated the reduction effects of kallistatin on NCI-H446 cell migration. a Transfected with negative control siRNA and treated with saline; b transfected with negative control siRNA and treated with 200 μg/ml kallistatin; c transfected with integrin β3 siRNA and treated with saline; d transfected with integrin β3 siRNA and treated with 200 μg/ml kallistatin; e treated with mouse IgG and saline; f treated with mouse IgG and 200 μg/ml kallistatin; g treated with integrin β3 antibody and saline; h treated with integrin β3 antibody and 200 μg/ml kallistatin. D Statistic analysis for the migrated cell numbers. Data were presented as mean ± SD (N = 6). *P < 0.05. # P < 0.05, # comparison of the differences between column 1 and 2 and between column 3 and 4, and the differences between column 5 and 6 and between 7 and 8

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Migration, Inhibition, Microscopy, Imaging, Membrane, Saline, Transfection, Negative Control, Comparison

    Kallistatin inhibits phosphorylation along the integrin signaling pathway. a 200 μg total cellular protein of each sample was used for immunoblotting analysis. Phosphorylation of integrin β3, FAK and Src was inhibited in a time-dependent manner by treatment of kallistatin, while each of their total protein levels showed undetectable change. (N = 3). The protein levels were normalized with β-actin. b – d The relative levels of phosphorylated integrin β3, phosphorylated FAK and phosphorylated Src proteins were calculated and plotted. The data are expressed as mean ± SD from three independent experiments (N = 3). *P < 0.05

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: Kallistatin inhibits phosphorylation along the integrin signaling pathway. a 200 μg total cellular protein of each sample was used for immunoblotting analysis. Phosphorylation of integrin β3, FAK and Src was inhibited in a time-dependent manner by treatment of kallistatin, while each of their total protein levels showed undetectable change. (N = 3). The protein levels were normalized with β-actin. b – d The relative levels of phosphorylated integrin β3, phosphorylated FAK and phosphorylated Src proteins were calculated and plotted. The data are expressed as mean ± SD from three independent experiments (N = 3). *P < 0.05

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Phospho-proteomics, Western Blot

    Kallistatin inhibits integrin β3-mediated PI3-K/AKT pathwaysignaling. a and e Using 200 μg total cellular proteins from each of the samples for immunoblotting analysis. The protein levels were normalized with β-actin. a Phosphorylation of AKT Erk1/2 and PI3 K were inhibited in a time-dependent manner without detectable change of their total AKT and Erk1/2 protein levels after treated with kallistatin (N = 3). ( b – d ) The relative levels of PI3 K, phosphorylated AKT and phosphorylated Erk1/2 proteins were calculated and plotted. The data are expressed as mean ± SD from three independent experiments (N = 3). *P < 0.05. f The relative levels of Grb2 proteins were calculated and plotted. The data are expressed as mean ± SD from three independent experiments (N = 3). *P < 0.05

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: Kallistatin inhibits integrin β3-mediated PI3-K/AKT pathwaysignaling. a and e Using 200 μg total cellular proteins from each of the samples for immunoblotting analysis. The protein levels were normalized with β-actin. a Phosphorylation of AKT Erk1/2 and PI3 K were inhibited in a time-dependent manner without detectable change of their total AKT and Erk1/2 protein levels after treated with kallistatin (N = 3). ( b – d ) The relative levels of PI3 K, phosphorylated AKT and phosphorylated Erk1/2 proteins were calculated and plotted. The data are expressed as mean ± SD from three independent experiments (N = 3). *P < 0.05. f The relative levels of Grb2 proteins were calculated and plotted. The data are expressed as mean ± SD from three independent experiments (N = 3). *P < 0.05

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Western Blot, Phospho-proteomics

    The proposed effect sites of kallistatin through integrin signaling pathway. Kallistatin inhibited the both of PI3 K/AKT and Erk/MAPK resulted in a downregulation of Bcl-2 expression for the anti-apoptotic homologs, and an upregulation for the pro-apoptotic homologs, and inhinited the phosphorylation integrin β3 and suppresses the expression of Grb2 for the cell migration

    Journal: Cancer Cell International

    Article Title: Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

    doi: 10.1186/s12935-016-0365-7

    Figure Lengend Snippet: The proposed effect sites of kallistatin through integrin signaling pathway. Kallistatin inhibited the both of PI3 K/AKT and Erk/MAPK resulted in a downregulation of Bcl-2 expression for the anti-apoptotic homologs, and an upregulation for the pro-apoptotic homologs, and inhinited the phosphorylation integrin β3 and suppresses the expression of Grb2 for the cell migration

    Article Snippet: Rabbit anti-human integrin β3, rabbit anti-human phospho-Integrin β3, and mouse anti-human integrin β3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Expressing, Phospho-proteomics, Migration